Impatto sul budget di un trattamento personalizzato dell’epatite B cronica HBeAg-negativa in Italia mediante peg-interferone alfa-2a associato alla stopping-rule alla 12a settimana-Reference-Cited by-同舟云学术

Impatto sul budget di un trattamento personalizzato dell’epatite B cronica HBeAg-negativa in Italia mediante peg-interferone alfa-2a associato alla stopping-rule alla 12a settimana

Published:2013-11-14 Issue:3 Volume:15 Page:123-130
ISSN:1590-9158
Container-title:PharmacoEconomics Italian Research Articles
language:it
Short-container-title:PharmacoEcon Ital Res Artic

Author:

Iannazzo Sergio,De Francesco Maria,Coco Barbara,Brunetto Maurizia Rossana,Tomic Radovan,Paolini Davide,Palmieri Giulio,Bonino Ferruccio

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Health Policy

Link

http://link.springer.com/content/pdf/10.1007/s40276-013-0015-1.pdf

Reference33 articles.

1. WHO (World Health Organization). Hepatitis B. Fact Sheet No. 204, July 2012. Disponibile su http://www.who.int/mediacentre/factsheets/fs204/en/ [Ultimo accesso maggio 2013].

2. EASL (European Association for the Study of the Liver). Clinical practice guidelines. Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–85.

3. AISF (Associazione Italiana per lo Studio del Fegato). Trattamento della infezione da HBV: documento di indirizzo dell’Associazione Italiana per lo Studio del Fegato. Febbraio 2004.

4. Brunetto R, Moriconi F, Bonino F, et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology. 2009;49:1141–50.

5. Brunetto MR. A new role for an old marker, HBsAg. J Hepatol. 2010;52:475–7.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimation of lifetime costs for patients receiving a transplant: the case of liver transplantation related to hepatitis B in Italy;Frontiers in Public Health;2024-07-03